Want to see IN:VIVIMEDLAB full AI Analyst Report?

Vivimed Labs Limited (VIVIMEDLAB) Financial Statements

1 Followers

Vivimed Labs Limited Financial Overview

Vivimed Labs Limited's market cap is currently ₹503.29M. The company's EPS TTM is ₹-21.28; its P/E ratio is -0.28; and it has a dividend yield of 0.67%. Vivimed Labs Limited is scheduled to report earnings on July 17, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 699.89M	₹ 1.16B	₹ 1.49B	₹ 1.87B	₹ 2.37B
Gross Profit	₹ -547.76M	₹ 77.98M	₹ 705.71M	₹ -928.65M	₹ 838.04M
Operating Income	₹ -1.78B	₹ -332.72M	₹ -148.14M	₹ -1.22B	₹ -250.73M
EBITDA	₹ -1.46B	₹ -86.77M	₹ -246.69M	₹ -1.86B	₹ -67.91M
Net Income	₹ -1.76B	₹ -319.61M	₹ -454.46M	₹ -3.29B	₹ -676.50M
Balance Sheet
Cash & Short-Term Investments	₹ 13.56M	₹ 7.08M	₹ 717.79M	₹ 37.62M	₹ 71.84M
Total Assets	₹ 7.53B	₹ 9.21B	₹ 9.51B	₹ 9.88B	₹ 12.66B
Total Debt	₹ 3.97B	₹ 3.76B	₹ 3.79B	₹ 3.81B	₹ 2.78B
Net Debt	₹ 3.96B	₹ 3.76B	₹ 3.77B	₹ 3.77B	₹ 2.71B
Total Liabilities	₹ 9.64B	₹ 9.56B	₹ 9.56B	₹ 9.49B	₹ 9.02B
Stockholders' Equity	₹ -2.11B	₹ -351.69M	₹ -54.61M	₹ 394.23M	₹ 3.64B
Cash Flow
Free Cash Flow	₹ 67.56M	₹ -86.28M	₹ -260.30M	₹ 303.54M	₹ -6.75B
Operating Cash Flow	₹ 77.03M	₹ -40.97M	₹ -239.91M	₹ 138.12M	₹ -6.58B
Investing Cash Flow	₹ -9.47M	₹ -45.31M	₹ 282.88M	₹ -49.68M	₹ 5.23B
Financing Cash Flow	₹ -61.07M	₹ 73.10M	₹ -60.32M	₹ -162.44M	₹ -103.80M

Currency in INR

Vivimed Labs Limited Earnings and Revenue History

Income Statement >

Vivimed Labs Limited Debt to Assets

Balance Sheet >

Vivimed Labs Limited Cash Flow

Cash Flow >

Vivimed Labs Limited Forecast EPS vs Actual EPS

Earnings >